Cross-immunity study of two experimentally oil-emulsion inactivated Infectious bronchitis vaccines in SPF chickens

Authors

  • . Shoshtari Department of Avian Diseases Research and Diagnostic, Razi Vaccine and Serum Research Institute, Karaj, Iran
  • M. Vasfi-Marandi Poultry Diseases Division, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
  • M.H. Bozorgmehrifard Poultry Diseases Division, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
  • R. Momayez Department of Avian Diseases Research and Diagnostic, Razi Vaccine and Serum Research Institute, Karaj, Iran
  • R. Toroghi Department of Research & Biotechnology, Razi Vaccine & Serum Research Institute, Mashhad, Iran.
Abstract:

A study has been carried out for determining of cross-immunity between Massachusetts (Mass) M41 and Iranian IR/773/2001 (793/B) strains of infectious bronchitis virus. Two groups of 20 three weeks old SPF chickens vaccinated subcutaneously with two oil-emulsions inactivated Infectious Bronchitis Vaccines (Mass M41 and Iranian IR/773/2001 strains) that had been manufactured in Razi institute in the laboratory scale. A further group of 20 SPF chickens were kept as non-vaccinated control. Four weeks post vaccination half part of the birds of the each vaccinated groups were challenged by eye drop with 103EID50 of M-41 strain of Mass serotype and another part of the birds of the each vaccinated groups were challenged with 103EID50 of Iranian IR/773/2001 793/B strain. The birds of the control group were also divided in two parts and challenged with the viruses (M-41 and IR/773/2001) like the birds of the vaccinated groups. Each of the birds of the vaccinated groups manifested a very strong resistance to homologous virus strains and only 10% of them showed ciliostasis in tracheal section examination. Whereas after challenge with heterologous virus strains, the vaccinated birds with IR/773/2001 killed vaccine revealed 50% resistance against M41 and the birds vaccinated with M41 killed vaccine only showed 30% immunity against IR/773/2001 based on the degree of 50% and 70% ciliostasis in tracheal section examination respectively. All of the control birds showed complete ciliostasis without any protection against the challenge of the both viruses. Upon the results, it is suggested that the distribution of 793/B serotype should be carefully studied in different parts of Iran for appropriate vaccination programmes against infectious bronchitis.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

cross-immunity study of two experimentally oil-emulsion inactivated infectious bronchitis vaccines in spf chickens

a study has been carried out for determining of cross-immunity between massachusetts (mass) m41 and iranian ir/773/2001 (793/b) strains of infectious bronchitis virus. two groups of 20 three weeks old spf chickens vaccinated subcutaneously with two oil-emulsions inactivated infectious bronchitis vaccines (mass m41 and iranian ir/773/2001 strains) that had been manufactured in razi institute in ...

full text

Immunogenicity and Efficacy of Live Infectious Bronchitis 793/B.08IR Vaccine in SPF Chickens

Infectious bronchitis virus (IBV) has a variety of serotypes with relatively limited cross-protection leading the disease to be a major problem in the poultry industry. The IBV 793/B strain has identified to circulate in Iran; therefore, the development of a specific vaccine to protect against the virulent virus has received attention. In this regard, the live IB 793/B vaccine (793/B.08IR) was ...

full text

Effectiveness of two H9N2 low pathogenic avian influenza conventional inactivated oil emulsion vaccines on H9N2 viral replication and shedding in broiler chickens

The objective of this study was to compare the effect of two conventional H9N2 avian influenza (AI) vaccines on replication and shedding of the H9N2 AI virus in broiler chickens. These inactivated oil emulsion vaccines contain either a UAE or an Iranian H9N2 AI isolate. One hundred and fifty one-day-old commercial broiler chickens were randomly divided into six groups. The birds, except for the...

full text

Comparison of Laboratory Parameters in the Serum of SPF Chickens Infected with Different Iranian Genotypes of Infectious Bronchitis Virus

Background and Aims: Infectious bronchitis (IB), caused by infectious bronchitis virus (IBV), is an acute and highly contagious disease in chickens. IBV is considered mainly as a respiratory infection, other clinical manifestations, including renal, enteric and reproductive signs can be observed. Since there has been no study on evaluation of changes in biochemical parameters during IB infect...

full text

Evaluation of Quality of Two Commercial Oil-Emulsion Newcastle Disease Vaccines In-vivo and In-vitro

Background and Aims: Newcastle disease (ND) is a highly contagious disease in poultry with economic losses in the world. Vaccination is one of the most important ways for prevention and control of NDV, but there are reports of ND outbreaks in vaccinated chickens. Poor quality of the vaccines is one of the reasons of vaccine failure. In this study the quality of two commercial oil-emulsion Newca...

full text

Comparison of clinico - pathological changes in SPF chickens infected with different Iranian genotypes of infectious bronchitis virus

Introduction: Infectious bronchitis (IB), caused by infectious bronchitis virus (IBV), is an acute and highly contagious disease in chickens. IBV is mainly considered a respiratory infection, other clinical manifestations, including renal, enteric and reproductive signs can be observed. Aim: Since there has been no study on evaluation of changes in biochemical parameters during IB infection, th...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 63  issue 2

pages  1- 9

publication date 2008-07-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023